[Skip to content]

Print this page
.

NICE Technology Appraisals

This is a list of the published NICE technology appraisals. Technology appraisals are recommendations on the use of new and existing medicines and treatments within the NHS.

NICE TAs: 1-20;  21-40;  41-60;  61-80;  81-100;  101-120121-140141-160;  161-180181-200201-220221-240241-260261-280; 281+

NICE TAs 101-120

 

REF

 

TITLE

 

DHFT Formulary link

East Midlands Cancer Network link (cancer drugs only)

TA101

Prostate cancer (hormone-refractory) - docetaxel (TA101)         

   

EMCN algorithm

DHFT protocol

TA102

Conduct disorder in children - parent-training/education programmes (TA102)

No drug implications

 

TA103

Psoriasis - efalizumab and etanercept (TA103)  

13.5.3 Drugs affecting the immune response

 

TA104 

Psoriatic arthritis - etanercept and infliximab (TA104) (replaced by TA199)

Withdrawn

 

TA105 

Colorectal cancer - laparoscopic surgery (review) (TA105)  

No drug implications

 

TA106 

Hepatitis C - peginterferon alfa and ribavirin (TA106)  

5.3 Antiviral drugs: 5.3.3 Viral Hepatitis

 

TA107

Breast cancer (early) - trastuzumab (TA107)

 

EMCN algorithm

DHFT protocol

TA108

Breast cancer (early) - paclitaxel (TA108)

 

Not supported

TA109

Breast cancer (early) - docetaxel (TA109)  

 

EMCN algorithm

DHFT protocol

TA110

Follicular lymphoma - rituximab (TA110) (replaced by TA243)

 

EMCN algorithm

DHFT protocol

TA111

Alzheimer's disease - donepezil, galantamine, rivastigmine (review) and memantine (TA111)

Replaced by TA217: 4.11 Drugs for dementia

 

TA112

Breast cancer (early) - hormonal treatments (TA112)

8.3 Sex hormones and hormone antagonists in malignant disease: 8.3.4.1 Breast cancer

EMCN algorithm

TA113

Diabetes (type 1 and 2) - inhaled insulin (TA113)

Withdrawn

 

TA114

Drug misuse - methadone and buprenorphine (TA114)

4.10 Substance abuse

 

TA115

Drug misuse - naltrexone (TA115)

4.10 Substance abuse

 

TA116

Breast cancer - gemcitabine (TA116)

 

EMCN algorithm

DHFT protocol 

TA117

Hyperparathyroidism - cinacalcet (TA117)

9.5 Minerals: 9.5.1.2 Hypercalcemia and Hypercalciuria

 

TA118

Colorectal cancer (metastatic) - bevacizumab and cetuximab (TA118) (partially updated by TA242)

 

See TA242

 

 

TA119

Leukaemia (lymphocytic) - fludarabine (TA119)

 

EMCN algorithm

DHFT protocol

TA120

Heart failure - cardiac resynchronisation (TA120)

No drug implications